# Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

> **NCT00443521** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 30 (—)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Triamcinolone Acetonide 4 mg intravitreal injection
- **PROCEDURE:** Panretinal photocoagulation

## Key facts

- **NCT ID:** NCT00443521
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443521, "Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00443521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*